JESSICA CHU: Open Payments
NPI 1407404312 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,299 in 62 payments from 12 companies in 2025. Trend: 2023 $1,352 · 2024 $1,232 · 2025 $1,299
Food & beverage: $1,299
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 21 | $426 |
| Gilead Sciences, Inc. | 16 | $345 |
| Merck Sharp & Dohme LLC | 6 | $161 |
| Theratechnologies Inc. | 3 | $69 |
| Novo Nordisk Inc | 4 | $66 |
| Amgen Inc. | 3 | $58 |
| EMD Serono, Inc. | 2 | $51 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
| Antares Pharma, Inc. | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: CABENUVA, PIFELTRO, APRETUDE, EGRIFTA, REXULTI, DOVATO, Wegovy, OTEZLA.
Industry payments across TX — which companies pay providers there.
